Learn about CFA’s position on Biotechnology


CFA’s overall goals on biotechnology are to work toward a government policy and regulatory framework that ensures that biotechnology developments are compatible with the needs and expectations of the marketplace and contribute to the success and economic well-being of farmers.

The evolution and development of the Canadian agriculture sector has been driven by research, innovation and adoption of new technology. Biotechnology research and development is a prominent part of this ongoing process.


CFA Recommendations

  • Research and development in biotechnology must be accompanied by the accumulation of sound factual information on the potential use, effect and safety of the biotechnology.
  • Consumer information and education must be an integral component of biotechnology development.
  • The legislative and regulatory framework, for agricultural biotechnology development and approval, must be balanced and respect the legitimate interests of both the developers of the technology and the farmers who may use the technology.
  • Decisions to approve new biotechnology developments must be sensitive to the requirements of the market place and enhance the marketing of Canadian agricultural products.
  • The risk of creating unreasonable costs associated with regulatory activities, and the risk of creating legal liabilities for producers or marketers should be considered prior to approval of new biotechnology developments.
  • Adequate resources must be provided for an effective, scientifically sound approach to biotechnology regulatory issues.

CFA is constantly working to turn these policies into legislation on behalf of Canadian farmers. Sign up to our newsletter for weekly updates on the work CFA is doing for you.

Learn about CFA’s position on Biotechnology


CFA’s overall goals on biotechnology are to work toward a government policy and regulatory framework that ensures that biotechnology developments are compatible with the needs and expectations of the marketplace and contribute to the success and economic well-being of farmers.

The evolution and development of the Canadian agriculture sector has been driven by research, innovation and adoption of new technology. Biotechnology research and development is a prominent part of this ongoing process.


CFA believes that:

  • Research and development in biotechnology must be accompanied by the accumulation of sound factual information on the potential use, effect and safety of the biotechnology.
  • Consumer information and education must be an integral component of biotechnology development.
  • The legislative and regulatory framework, for agricultural biotechnology development and approval, must be balanced and respect the legitimate interests of both the developers of the technology and the farmers who may use the technology.
  • Decisions to approve new biotechnology developments must be sensitive to the requirements of the market place and enhance the marketing of Canadian agricultural products.
  • The risk of creating unreasonable costs associated with regulatory activities, and the risk of creating legal liabilities for producers or marketers should be considered prior to approval of new biotechnology developments.
  • Adequate resources must be provided for an effective, scientifically sound approach to biotechnology regulatory issues.

CFA is constantly working to turn these policies into legislation on behalf of Canadian farmers. Sign up to our newsletter for weekly updates on the work CFA is doing for you.

Learn about CFA’s position on Biotechnology


CFA’s overall goals on biotechnology are to work toward a government policy and regulatory framework that ensures that biotechnology developments are compatible with the needs and expectations of the marketplace and contribute to the success and economic well-being of farmers.

The evolution and development of the Canadian agriculture sector has been driven by research, innovation and adoption of new technology. Biotechnology research and development is a prominent part of this ongoing process.


CFA believes that:

  • Research and development in biotechnology must be accompanied by the accumulation of sound factual information on the potential use, effect and safety of the biotechnology.
  • Consumer information and education must be an integral component of biotechnology development.
  • The legislative and regulatory framework, for agricultural biotechnology development and approval, must be balanced and respect the legitimate interests of both the developers of the technology and the farmers who may use the technology.
  • Decisions to approve new biotechnology developments must be sensitive to the requirements of the market place and enhance the marketing of Canadian agricultural products.
  • The risk of creating unreasonable costs associated with regulatory activities, and the risk of creating legal liabilities for producers or marketers should be considered prior to approval of new biotechnology developments.
  • Adequate resources must be provided for an effective, scientifically sound approach to biotechnology regulatory issues.

CFA is constantly working to turn these policies into legislation on behalf of Canadian farmers. Sign up to our newsletter for weekly updates on the work CFA is doing for you.

Learn about CFA’s position on Biotechnology


CFA’s overall goals on biotechnology are to work toward a government policy and regulatory framework that ensures that biotechnology developments are compatible with the needs and expectations of the marketplace and contribute to the success and economic well-being of farmers.

The evolution and development of the Canadian agriculture sector has been driven by research, innovation and adoption of new technology. Biotechnology research and development is a prominent part of this ongoing process.


CFA believes that:

  • Research and development in biotechnology must be accompanied by the accumulation of sound factual information on the potential use, effect and safety of the biotechnology.
  • Consumer information and education must be an integral component of biotechnology development.
  • The legislative and regulatory framework, for agricultural biotechnology development and approval, must be balanced and respect the legitimate interests of both the developers of the technology and the farmers who may use the technology.
  • Decisions to approve new biotechnology developments must be sensitive to the requirements of the market place and enhance the marketing of Canadian agricultural products.
  • The risk of creating unreasonable costs associated with regulatory activities, and the risk of creating legal liabilities for producers or marketers should be considered prior to approval of new biotechnology developments.
  • Adequate resources must be provided for an effective, scientifically sound approach to biotechnology regulatory issues.

CFA is constantly working to turn these policies into legislation on behalf of Canadian farmers. Sign up to our newsletter for weekly updates on the work CFA is doing for you.